David Brown Email & Phone Number

Gaithersburg, Md, Us

- Manage a diverse array of departments including CMC, synthetic biology, informatics, US operations. - Responsibilities include new product design, IP management, and external CDMO management- Co-lead IND filing efforts in USA and China- Oversee the general management of the US site, ensuring smooth operations and developing strategic research initiatives.

- Managed (3) departments at RNAimmune: synthetic biology, CMC, and bioinformatics.- Directed efforts to design (3) next-generation mRNA vaccines against respiratory viruses.- Project manager for all CMC efforts, overseeing compliance with regulatory agencies and coordinating with external stakeholders.

- Supervised (2) design of experiments (DoE) projects resulting in a 40% reduction in IVT costs.- Managed the design and manufacturing of (2) mRNA-based drug products from conception to US IND filing.- Led a team in GMP manufacturing through CDMOs for successful drug product development.

- Designed new synthetic biology platforms completely from scratch, including DNA assembly and IVT. - Succeeded in producing several mRNA vaccine candidates from conception, DNA synthesis, mRNA production, and LNP formulation in 15 days.- Supervised the design layout and floor plan of new lab and office space capable of holding 9 labs and up to 60 people. Supervised the construction, permitting, changes, moving, and start-up to new facility.- Designed and constructed >100 mRNA vaccine candidates for COVID, RSV, influenza, cancer vaccines, HSV, Rabies, and enteroviruses using bioinformatic, AI, protein engineering, and cycle of design approaches, resulting in several patent applications.

La Jolla, Ca, Us

- co-invented a new human artificial chromosome and delivery method, now published in Science.- Developed an assay for detecting viral host defense inhibitors. - Engaged in the construction, delivery, and testing of several de novo human artificial chromosomes and other large DNA molecules- Developed a neuroblastoma-derived neuronal cell line as a cell culture model that show differential replication of historic and contemporary neurotropic EV-D68 strains. Additionally, developed a reverse genetics method for EV-D68- Assisted in the development of a Multivalent Rhinovirus Vaccine sponsored by GSK

La Jolla, Ca, Us

-Developed and optimized methods to transfer large DNA molecules cloned in yeast into cultured mammalian cells. Adapted this method to deliver the herpes simplex virus genome cloned in yeast into mammalian cells to produce infectious virus, creating a novel reverse genetics system- Assisted in the development of DNA assembly methods responsible for rapidly synthesizing influenza seeds which was utilized in the influenza vaccine produced by Novartis.

Phd, Molecular & Cellular Biology

B.A., Biochemistry/Molecular Biology